§ Same category · GLP-1 / metabolic peptides
Orforglipron vs Semaglutide
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Orforglipron
0
vendors tracked
Semaglutide
0
vendors tracked
Orforglipron
Oral small-molecule GLP-1 agonist
No current listings at 0.024mg.
Semaglutide
GLP-1 agonist for metabolic research
No current listings at 5mg.
About Orforglipron
An oral non-peptide GLP-1 receptor agonist in Phase 3 for obesity and type-2 diabetes. Typically sold as capsules in research-compound form.
About Semaglutide
A once-weekly GLP-1 receptor agonist studied for glycemic control and weight loss. Approved as a prescription drug in many jurisdictions; research-peptide vendors supply the compound for laboratory use.